# Live Pharmacovigilance Evidence and Drug Safety Intelligence Pipeline v1

## Final Deliverable Report

**Developer:** Sarvesh Patil  
**Project:** AI Biotech – Core Task 1  
**System:** Pharmacovigilance Evidence and Drug Safety Intelligence Pipeline v1

---

## 1. Project Overview

This project implements a pharmacovigilance evidence and drug safety intelligence pipeline designed to retrieve, process, validate, normalize, and store drug safety evidence from the OpenFDA/FAERS public data source.

The system is an evidence-retrieval and intelligence pipeline and is not intended to provide diagnosis, treatment recommendations, or clinical decision-making.

---

## 2. Source Code Implementation

The implementation contains the following major components:

- OpenFDA evidence connector
- Drug/entity resolution
- Evidence normalization
- Evidence schema validation
- Evidence storage
- Duplicate evidence protection
- Production monitoring
- Error handling
- Automated test suite
- End-to-end pipeline verification

The implementation preserves evidence provenance including source information, source record identifiers, retrieval timestamps, and source URLs.

---

## 3. System Verification

The automated test suite was executed using:

    pytest -q

### Result

    47 passed

The test suite successfully verified the implemented pipeline components and production-phase functionality.

---

## 4. Production Monitoring

Production monitoring functionality is included in the project through the monitoring component.

The monitoring layer is intended to provide visibility into pipeline execution, including execution events and operational failures.

This supports production-oriented observation of the evidence pipeline without changing the scientific evidence model.

---

## 5. Error Boundary Safety

Error-handling functionality is included to prevent unexpected pipeline failures from terminating the application without controlled handling.

The test suite includes dedicated error-handler verification.

The system is designed to handle external API and runtime failures through controlled error handling.

---

## 6. End-to-End Integration Verification

The complete pipeline was verified through the integrated application flow:

    Drug Input
        ↓
    OpenFDA Retrieval
        ↓
    Entity Resolution
        ↓
    Evidence Normalization
        ↓
    Schema Validation
        ↓
    Evidence Storage

The project contains a dedicated end-to-end integration test.

---

## 7. Runtime Verification

The production application was executed using:

    python app.py

A runtime search was performed for:

    ibuprofen

The application successfully connected to OpenFDA and returned:

    Records found: 5

The application displayed structured evidence including:

- Evidence ID
- Drug
- Entity resolution status
- Canonical entity
- Adverse event
- Association type
- Source
- Source record ID
- Evidence type
- Retrieval timestamp

The runtime execution completed successfully.

---

## 8. Evidence Provenance

Evidence records preserve source provenance information.

The implementation records OpenFDA/FAERS as the evidence source and retains source record identifiers and retrieval information.

This allows stored evidence to be traced back to its originating source record.

---

## 9. Duplicate Evidence Protection

The evidence store checks existing source record identifiers before adding new evidence.

During runtime verification, previously stored evidence records were detected and:

    New evidence records saved: 0

This demonstrates that duplicate evidence was not unnecessarily inserted during the verification run.

---

## 10. Integration Contract Validation

The pipeline components operate through defined evidence structures and validation rules.

The integration verifies the flow between:

- Evidence retrieval
- Entity resolution
- Normalization
- Schema validation
- Evidence storage

The automated test suite provides verification of these component boundaries.

---

## 11. Test Coverage

The project contains tests covering:

- Entity resolution
- Evidence schema
- Evidence storage
- Evidence normalization
- Monitoring
- Error handling
- End-to-end pipeline execution
- Phase-level verification

Final automated verification result:

    47 passed

---

## 12. Production Runtime Result

Runtime verification confirmed that the application can:

1. Accept a drug search input.
2. Retrieve evidence from OpenFDA/FAERS.
3. Process retrieved records.
4. Resolve drug entities.
5. Normalize evidence.
6. Validate evidence.
7. Display structured evidence.
8. Prevent duplicate evidence storage.

---

## 13. Known Limitations

- Evidence retrieval depends on availability of the external OpenFDA API.
- Pharmacovigilance reports represent reported safety information and do not by themselves establish causality.
- The system is an evidence intelligence pipeline and not a clinical decision-support or diagnostic system.
- Entity resolution may remain unresolved for records that cannot be confidently mapped to a canonical entity.

---

## 14. Production Readiness Certification

The Pharmacovigilance Evidence and Drug Safety Intelligence Pipeline v1 was subjected to automated testing and runtime verification.

The final verification demonstrated:

- 47 automated tests passed.
- The application successfully executed at runtime.
- OpenFDA evidence retrieval was successfully demonstrated.
- Structured pharmacovigilance evidence was produced.
- Evidence provenance was preserved.
- Duplicate evidence protection was demonstrated.
- End-to-end pipeline functionality was verified.

Based on the completed automated and runtime verification activities, the implementation is ready for submission as the completed production-phase deliverable, subject to the documented limitations and external API dependency.

---

## 15. Conclusion

The production-phase verification of the Live Pharmacovigilance Evidence and Drug Safety Intelligence Pipeline v1 has been completed.

The system now includes automated verification, runtime verification, monitoring and error-handling components, evidence provenance, entity resolution, schema validation, and duplicate-safe evidence storage.

**Final automated test result: 47 passed.**

**Runtime verification: Successful.**